Ignite Creation Date:
2024-05-05 @ 11:22 AM
Last Modification Date:
2024-10-26 @ 9:03 AM
Study NCT ID:
NCT00002746
Status:
COMPLETED
Last Update Posted:
2019-02-27
First Post:
1999-11-01
Brief Title:
Interleukin-2 in Treating Patients With Myelodysplastic Syndrome
Sponsor:
University of Washington
Organization:
University of Washington
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Leukemia |
| Myelodysplastic Syndromes |
| MyelodysplasticMyeloproliferative Neoplasms |
Keywords:
| Name | View |
|---|---|
| refractory anemia | View |
| refractory anemia with ringed sideroblasts | View |
| refractory anemia with excess blasts | View |
| chronic myelomonocytic leukemia | View |
| de novo myelodysplastic syndromes | View |
| previously treated myelodysplastic syndromes | View |
| secondary myelodysplastic syndromes | View |
| atypical chronic myeloid leukemia BCR-ABL1 negative | View |
| myelodysplasticmyeloproliferative neoplasm unclassifiable | View |
| childhood myelodysplastic syndromes | View |